Chlamydia pneumoniae Accelerates Coronary Artery Disease Progression in Transgenic Hyperlipidemia-Genetic Hypertension Rat Model

Molecular Medicine

Volumn 9, Issue 5-8, 2003, Pages 135-142

  Herrera, Victoria L M ^a   Shen, L I ^a   Lopez, Lyle V ^a   Didishvili, Tamara ^a   Zhang, You Xun ^a   Ruiz Opazo, Nelson ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ACCELERATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL SURVIVAL; CARDIOVASCULAR RISK; CHEMOSENSITIVITY; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FOAM CELL; GENETIC TRANSCRIPTION; HEART ATRIUM THROMBOSIS; HEATING; HEREDITARY HYPERTENSION; HYPERLIPIDEMIA; HYPERTENSION; INBREEDING; INOCULATION; MACROPHAGE; MALE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PNEUMONIA; PRIORITY JOURNAL; RAT; RAT STRAIN; STAGING; TRANSGENIC ANIMAL;

EID: 0142147212     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402178     Document Type: Article

References (30)

1. Deloger-Pedersen S, Pederson EM, Ringgaard S, Falk E. (1999) Coronary artery disease: plaque vulnerability, disruption ond thrombosis. In: The vulnerable atherosclerotic plaque. Fuster V (ed.) Futura, Inc., New York, N.Y. pp. 1-23.
2. Saikku P et al. (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983-6.
3. Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA (1993) Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streak and fibrolipid plaques. J. Clin. Microbiol. 31:2212-4.
4. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. (1996) Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J. Clin. Pathol. 49:102-6.
5. Ramirez JA. (1996) Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann. Intern. Med. 125:979-82.
6. Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. (1999) Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: the final report of the ROXIS Study. Eur. Heart J. 20:121-7.
7. Anderson JL et al. (1999) Randomized secondary prevention trial of azithromycin inpatients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation 99:1540-7.
8. Muhlstein JB, Anderson JL, Hammon EH, Zhao L, Trehan S, Schowobe E, Carlquist JF. (1998) Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97:633-6.
9. Blessing E, Campbell LA, Rosenfeld ME, Chough N, Kuo CC. (2001) Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158:13-7.
10. Hu H, Pierce GN, Zhong G. (1999) The atherogenic effects of Chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Invest. 103:747-53.
11. Moazed T, Campbell LA, Rosenfeld ME, Grayston JT, Kuo CC. (1999) Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J. Infect. Dis. 180:238-41.
12. Burnett MS, Gaydos CA, Madico GE, Glad SM, Paigen B, Quinn TC, Epstein SE. (2001) Atherosclerosis in apoE knockout mice infected with multiple pathogens. J. Infect. Dis. 183:226-31.
13. Ezzahiri R et al. (2002) Chlamydophila pneumoniae (Chlamydia pneumonaie) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice. Cardiovasc. Res. 56:269-76.
14. Caligiuri G, Rottenberg M, Nicoletti A, Wigzell H, Hansson GK. (2001). Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 103:2834-8.
15. Aalto-Setala K, Laitinen K, Kerkkila L, Leinonen M, Jauhiainen M, Ehnholm C, Tamminen M, Puolakkainen M, Penttila I, Saikku P. (2001). Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:578-84.
16. Blessing E, Nagano S, Campbell LA, Rosenfeld ME, Kuo CC. (2000) Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice. Infect. Immun. 68:7195-7.
17. Herrera VLM et al. (2001) Hypertension exacerbates coronary artery disease in transgenic hyperlipidemic Dahl salt-sensitive hypertensive rats. Mol. Med. 7:831-44.
18. Kalayoglu MV, Byrne GI. (1998) A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect. Immunity 66:5067-72.
19. Herrera VLM, Didishvili T, Lopez LV, Ruiz-Opazo N. (2002) Differential regulation of functional gene clusters in overt coronary artery disease in a transgenic atherosclerosis-hypertensive rat model. Mol. Med. 8:367-75.
20. Kalayoglu MV, Byrne GI. (1998) Induction of macrophage foam cell formation by Chlamydia pneumoniae. J. Infect. Dis. 177:725-9.
21. Churchill GA. (2002) Fundamentals of experimental design for cDNA microarrays. Nature Genetics (Suppl) 32:490-5.
22. Quackenbush J. (2002) Microarray data normalization and transformation. Nature Genetics (Suppl) 32:496-501.
23. Kol A, Sukhova GK, Lichtman AH, Libby P. (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98:300-7.
24. Epstein SE, Zhou YF, Zhu J. (1999). Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100:e20-8.
25. Taub D, Sayers T, Carter C, Ortaldo J. (1995) Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877-88.
26. Neville LF, Mathiak G, Bagasra O. (1997) The immunobiology of interferon-γ inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev. 8:207-19.
27. Kokame K, Kato H, Miyata T. (1998). Nonradioactive differential display cloning of genes induced by homocysteine in vascular endothelial cells. Methods 16:434-43.
28. Kuhl NM, Keyser J, De Vries H. Hoekstra D. (2002) Insulin-like growth factor binding proteins-1 and -2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro. J. Neurosci. 69:207-16.
29. Coombs GH, Wolf CR, Morrison VM, Craft JA. (1990) Changes in hepatic xenobiotic-metabolising enzymes in mouse liver following infection with Leishmania donovani. Mol. Biochem. Parasitol. 41:17-24.
30. Sewer MB, Koop DR, Morgan ET. (1996) Endotoxemia in rats is associated with induction of the P450A subfamily and suppression of several other forms of cytochrome P450. Drug Metabolism Dispos. 24:401-7.